article
Drug Target Review – Issue #3 2015
21 September 2015 | By Drug Target Review
Included in this issue: Drug Development, Microfluidics, Proteomics, Ion Channels, GPCR, Imaging, Flow Cytometry, Enzymes
List view / Grid view
Hit-to-Lead
news
Dr Jeanette Wood joins Nuevolution as Scientific Advisor
21 September 2015 | By Victoria White
Dr Wood's expertise and experience to support Nuevolution in developing its pipeline in oncology, inflammation and immuno-oncology...
news
Selvita expands its operations into the US
21 September 2015 | By Victoria White
Appreciating the importance of the US biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc...
article
Microfluidic technology: the next-generation drug discovery tool
Microfluidic miniaturisation, or the so-called ‘lab-on-a-chip’ concept, now encroaches on the fields of biology, medicine and pharmacology, and the nature of microfluidic technology (small volumes and high-throughput integration of fluid connections) means that it is outperforming conventional bench work. There has been an incredible need for microfluidic technology in the…
article
SOMAscan™ assay: a vital proteomic tool in drug discovery
21 September 2015 | By SomaLogic
The SOMAscan™ assay is a highly multiplexed, sensitive, quantitative and reproducible proteomic tool for discovering biomarkers for drug discovery...
article
The importance of measuring drug target residence times
21 September 2015 | By BioTek
The Synergy Neo2 Multi-Mode Reader is designed to provide high temporal resolution in drug target kinetics applications...
article
Enzymes: Ubiquitin-specific proteases as druggable targets
In much the same way that kinases and phosphatases attach and remove phosphate groups from proteins to modulate their activity, there are a series of enzymes (E1, E2, E3) that add one or more ubiquitins onto a protein, as well as enzymes that remove them (deubiquitinases; DUBs), thereby regulating their…
news
Researchers identify possible ovarian cancer biomarkers
17 September 2015 | By Victoria White
The researchers also determined that the level of biomarkers associated with ovarian cancer does not simply increase or decrease over the course of the disease...
news
Amgen and Xencor enter cancer immunotherapy and inflammation collaboration
17 September 2015 | By Victoria White
The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform...
news
Dementia Consortium funds project focusing on ALS and FTLD
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
news
Auspherix and Domainex expand antibiotics partnership
15 September 2015 | By
Since initiating the project in 2014, significant progress has been made towards the invention of new compounds with activity against both gram-positive and gram-negative bacteria...
webinar
Immunology Screening on the iQue Screener
14 September 2015 | By IntelliCyt
Immunology Screening on the iQue Screener: Assays for Immune-Modulators and Immunotherapy...
news
Transatlantic partnership to develop treatments for pancreatic cancer
14 September 2015 | By Victoria White
The five-year programme will focus on the development of ‘nanomedicine’ in the treatment of pancreatic cancer, for which current treatment options are limited...
news
Cancer Research UK and MedImmune launch biotherapeutics research centre
14 September 2015 | By Victoria White
The new laboratory, opened in Cambridge, will focus on the discovery and development of novel biologic cancer treatments and diagnostics...
news
Researchers discover new group of antibiotics
14 September 2015 | By Victoria White
The potential new antibiotics are unlike contemporary antibiotics because they contain iridium, a silvery-white transition metal...
